Strategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines현재 사용 가능한 COVID-19 백신에 저항할 가능성이 있는 새로 분류된 관심 변종인 SARS-CoV-2 Mu에 대처하기 위한 전략Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), MERS, SARS, 변종, 유전자 메커니즘, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration adopted approach B.1 lineage B.1.621 BNT161b2 booster dose Characteristics coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccine COVID-19 vaccine development Evidence exacerbated Genetic genomic Genomic surveillance global mass vaccination Health implementation infections Intervention Lineage mass vaccination Mu variant mutations Neutralizing non-pharmaceutical interventions (NPIs) NPIs potential risk public health measure public health measures Recombination reported required respiratory restrict SARS-CoV-2 SARS-CoV-2 B.1.621 SARS-CoV-2 virus sera shown Strains Strategy sub-lineage B.1.621.1 Surveillance survivor the SARS-CoV-2 virus therapeutic threat vaccination Vaccine vaccine breakthrough. Vaccine development variant variants [DOI] 10.1080/21645515.2022.2027197 PMC 바로가기 [Article Type] Article
Severe Acute Respiratory Syndrome Coronavirus 2 Infection Versus Vaccination in Pregnancy: Implications for Maternal and Infant Immunity중증 급성 호흡기 증후군 코로나바이러스 2 감염 대 임신 중 예방 접종: 산모 및 영아 면역에 미치는 영향Article Published on 2022-08-152022-09-12 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 진단, [키워드] acute respiratory syndrome anti-S anti-S IgG benefit BNT161b2 BNT162b2 vaccine booster breastmilk Cohort coronavirus coronavirus 2 COVID-19 determine dose ENhance Future IgA IgG Immunity immunization Immunoglobulin immunoglobulin A induce Infant infected with SARS-CoV-2 Infection lactating women lactation Maternal mother mucosal Neonatal Newborn of BNT162b2 outcomes placental positive correlation Pregnancy pregnancy. pregnant recruited respiratory SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccination SARS-CoV-2 vaccine serum significantly higher susceptible transfer uninfected vaccination Vaccine virus [DOI] 10.1093/cid/ciac359 PMC 바로가기 [Article Type] Article
Characterization of the significant decline in humoral immune response six months post-SARS-CoV-2 mRNA vaccination: A systematic reviewSARS-CoV-2 mRNA 백신 접종 후 6개월 후 체액성 면역 반응의 현저한 감소 특성: 체계적인 검토Review Published on 2022-07-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration age anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody anti-Spike IgG antibody Antibody Response Antibody titer Antibody titers appearance article binding domain BNT161b2 BNT162b2 booster Breakthrough infection breakthrough infections calculated characterization Comorbidities coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 mRNA Vaccination determine Effect Efficacy Evidence exhibited Factor finding highlight humoral humoral immune response Humoral immunity Humoral response IgG Immunoglobulin Immunoglobulin G independent independent of Kinetics Longitudinal data Messenger RNA Moderna mRNA mRNA 1273 mRNA BNT162b2 mRNA vaccination mRNA-1273 Participants peak levels Pfizer-BioNTech postvaccination presence of comorbidities reached reported respiratory second dose serostatus Serum level serum levels severe acute respiratory syndrome Coronavirus Sex systematic review Vaccination strategy Vaccine Vaccines Vaccines. variant waning immunity was performed [DOI] 10.1002/jmv.27688 PMC 바로가기 [Article Type] Review
Live virus neutralization testing in convalescent patients and subjects vaccinated against 19A, 20B, 20I/501Y.V1 and 20H/501Y.V2 isolates of SARS-CoV-2SARS-CoV-2의 19A, 20B, 20I/501Y.V1 및 20H/501Y.V2 분리주에 대한 백신 접종을 받은 회복기 환자 및 피험자의 생 바이러스 중화 테스트Letter Published on 2021-08-012022-09-10 Journal: Emerging Microbes & Infections [Category] SARS, 변종, 진단, [키워드] 20B 20h/501Y.V2 20I/501Y.V1 antibody Antibody titers antigenicity B.1.1.7 B.1.1.7 lineage B.1.351 BNT161b2 Cell collected conformational change conformational changes convalescent convalescent patient COVID-19 Critical critical COVID-19 patients critical patients groups HCW HCWs healthcare worker Humoral response induce Infection initial isolate lead Lineage Live virus live virus neutralization test Mild Modification modifications neutralization neutralization ability neutralization capacity neutralization test Neutralizing antibody titer neutralizing antibody titers neutralizing capacity no significant difference Patient patients Pfizer-BioNTech Population post infection Prevent reduction in SARS-CoV-2 SARS-CoV-2 mutation serum sample serum samples significant decrease significant difference Spike protein strain subject the spike protein variant variant of concern Virus neutralization [DOI] 10.1080/22221751.2021.1945423 PMC 바로가기 [Article Type] Letter